Risk factors for development of more than 5% MNCs of hematogone based on univariate and multivariate analyses
| . | BMT . | CBT . | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate . | Multivariate . | Univariate . | Multivariate . | |||||
| Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | |
| Infections, Yes/No | 0.19 (0.05-0.74) | .03 | 0.42 (0.02-1.58) | .23 | 0.16 (0.04-0.57) | < .01 | 0.37 (0.02-2.81) | .10 |
| Acute GVHD, Grade II-IV/0-I | 0.09 (0.01-0.73) | < .01 | 0.04 (0.00-0.85) | .03 | 0.12 (0.03-0.48) | < .01 | 0.04 (0.00-0.80) | .04 |
| . | BMT . | CBT . | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate . | Multivariate . | Univariate . | Multivariate . | |||||
| Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | Odds ratio (95% CI) . | P . | |
| Infections, Yes/No | 0.19 (0.05-0.74) | .03 | 0.42 (0.02-1.58) | .23 | 0.16 (0.04-0.57) | < .01 | 0.37 (0.02-2.81) | .10 |
| Acute GVHD, Grade II-IV/0-I | 0.09 (0.01-0.73) | < .01 | 0.04 (0.00-0.85) | .03 | 0.12 (0.03-0.48) | < .01 | 0.04 (0.00-0.80) | .04 |
BMT indicates bone marrow transplantation; CBT, cord blood transplantation; CI, confidence interval; GVHD, graft-versus-host disease; and MNC, mononuclear cell.